Crystalline forms of perindopril erbumine

Details Crystalline forms of perindopril erbumine Crystalline forms of perindopril erbumine

2011-07-19

2011-07-19

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S514000

Reexamination Certificate

active

07981921

ABSTRACT:
Disclosed are two new crystalline forms, δ and ε, of perindopril erbumine. Those forms are suitable as therapeutic active substances for medicaments for the treatment of cardiovascular diseases, especially high blood pressure and heart failure. The ε crystalline form is obtained in the crystallization of perindopril erbumine at from 30 to 45° C., preferably from 34 to 45° C., from MTBE containing from 1.5 to 2.5% (v/v) water; the crystallization is advantageously carried out with stirring. If the water is then removed, advantageously by azeotropic distillation, preferably at from 35 to 37° C., and stirring is then continued for at least 15 h at from 30 to 45° C., preferably from 35 to 37° C., the ε crystalline form is converted to the δ crystalline form. The δ crystalline form can also be obtained by stirring the α or β crystalline form at from 33 to 38° C. in tert.-butyl methyl ether containing from 0.9 to 1.4% (v/v) water with seeding with the δ crystalline form. The ε crystalline form can also be obtained by stirring the α or β crystalline form at from 28 to 35° C. in tert.-butyl methyl ether containing from 0.9 to 1.4% (v/v) water with seeding with the ε crystalline form; or by stirring the α or β crystalline form at from 35 to 38° C. in tert.-butyl methyl ether containing from 1.5 to 2.0% (v/v) water.

REFERENCES:
patent: 4508729 (1985-04-01), Vincent et al.
patent: 4914214 (1990-04-01), Vincent et al.
patent: 2003/0158121 (2003-08-01), Pfeiffer et al.
patent: 2003/0186896 (2003-10-01), Pfeiffer et al.
patent: 2004/0029813 (2004-02-01), Pfeiffer et al.
patent: 2007/0178166 (2007-08-01), Bernstein et al.
patent: 0049658 (1982-04-01), None
patent: 0308341 (1989-03-01), None
patent: 1256590 (2002-11-01), None
patent: WO 01/58868 (2001-08-01), None
patent: WO 01/83439 (2001-11-01), None
patent: WO 01/87835 (2001-11-01), None
patent: WO 01/87836 (2001-11-01), None
patent: WO 2004/046172 (2004-06-01), None

Affiliated with

Also associated with

Rating

Crystalline forms of perindopril erbumine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline forms of perindopril erbumine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of perindopril erbumine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2627730